ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1908

Multinational Evidence-Based Recommendations for Diagnosis and Management of Gout: Integrating Systematic Literature Research and Expert Opinion of a Broad Panel of Rheumatologists in the 3E Initiative

Mariano Andres1, Francisca Sivera2, Alison Kydd3, John Moi4, Rakhi Seth5, Melonie K. Sriranganathan6, Caroline van Durme7, Irene AAM van Echteld8, Ophir Vinik9, Mihir D. Wechalekar10, Daniel Aletaha11, Claire Bombardier9, Rachelle Buchbinder12, Loreto Carmona13, Christopher J. Edwards14, R. Landewe15 and Désirée van der Heijde16, 1Seccion Reumatologia, Hospital General Universitario de Alicante, Alicante, Spain, 2Sección de Reumatología, Hospital General Universitario de Elda, Alicante, Spain, 3Division of Rheumatology, University of British Columbia, Vancouver, BC, Canada, 4Royal Melbourne Hospital, Melbourne, Australia, 5Rheumatology, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom, 6Rheumatology, St. Mary's Hospital, Isle of Wight, United Kingdom, 7Maastricht University Medical Centre, Maastricht, Netherlands, 8Atrium Medical Center, Heerlen, Netherlands, 9Rheumatology, University of Toronto, Toronto, ON, Canada, 10Flinders University School of Medicine, Adelaide, Australia, 11Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, 12Monash Department of Clinical Epidemiology at Cabrini Hospital, Department of Epidemiology and Preventive Medicine, Monash University, Malvern, Victoria, Australia, 13Health Sciences School, Universidad Camilo José Cela, Villanueva de la Cañada, Spain, 14NIHR Wellcome Trust Clinical Research Facility, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom, 15Division of Clinical Immunology and Rheumatology, Academic Medical Center / University of Amsterdam, Amsterdam, Netherlands, 16Rheumatology, Leiden University Medical Center, Leiden, Netherlands

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: diagnosis, gout and treatment

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Metabolic and Crystal Arthropathies

Session Type: Abstract Submissions (ACR)

Background/Purpose: The 3e (Evidence, Expertise, Exchange) Initiative is a multinational collaboration that aims to promote evidence-based medicine in rheumatology. The 2011-12 3e Initiative aimed to develop evidence-based recommendations for the diagnosis and management in patients with gout by integrating evidence and the expert opinion of a broad international panel of rheumatologists.

Methods: 474 rheumatologists from 14 countries participated. Using a formal voting process, a panel of 78 rheumatologists developed a list of 10 clinical questions, 9 regarding the diagnosis and management of gout, and 1 focused on the management of asymptomatic hyperuricaemia. Bibliographic fellows undertook a systematic literature review for each clinical question. A literature search was performed using MEDLINE, EMBASE, Cochrane CENTRAL, and abstracts from 2010-11 EULAR and ACR meetings. Relevant studies were retrieved for data extraction and synthesis, and assessment of risk of bias. Using this evidence, rheumatologists from each country developed a set of national recommendations. Finally, multinational recommendations were formulated and assessed for agreement among the participants and the potential impact on clinical practice.

Results: In total, 42,823 references were identified, from which 325 studies were included in the systematic reviews. Combining this evidence and clinical expertise, the initial questions led to a set of 10 recommendations. Oxford Levels of Evidence were applied to each recommendation. One recommendation related to the potential role of clinical and laboratory data for the diagnosis of gout in the absence of crystal identification. Two recommendations considered screening for, and the management of cardiovascular and renal co-morbidities. Six recommendations focused on different aspects of the management of gout, with one recommendation considering a suitable treatment target and how to monitor patients. The last recommendation regarded the management of asymptomatic hyperuricaemia in order to prevent gout and renal and cardiovascular outcomes. The level of agreement by participants with the recommendations ranged from 8.1 to 9.2 (mean 8.7) on a 1-10 point scale with 10 representing full agreement. 17% (range 7.5-31.5%) of rheumatologists reported that the final set of recommendations would change their practice, and 79% (range 60.8-88.7%) felt that these recommendations were in accordance with their current practice.

Conclusion: Ten recommendations on the diagnosis and management of gout were established. They are evidence-based and supported by a large panel of rheumatologists from 14 countries, thus enhancing their utility in clinical practice.


Disclosure:

M. Andres,
None;

F. Sivera,
None;

A. Kydd,
None;

J. Moi,
None;

R. Seth,
None;

M. K. Sriranganathan,
None;

C. van Durme,
None;

I. A. van Echteld,
None;

O. Vinik,
None;

M. D. Wechalekar,
None;

D. Aletaha,
None;

C. Bombardier,
None;

R. Buchbinder,
None;

L. Carmona,
None;

C. J. Edwards,
None;

R. Landewe,
None;

D. van der Heijde,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/multinational-evidence-based-recommendations-for-diagnosis-and-management-of-gout-integrating-systematic-literature-research-and-expert-opinion-of-a-broad-panel-of-rheumatologists-in-the-3e-initiativ/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology